Measuring Retinal Vessel Caliber in Relation to Dark Adaptation and Blood Glucose Level

Overview

The overall objective is to investigate, whether retinal blood vessel diameter change during the energy consuming dark adaptation process and if responses vary between low and high blood glucose.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: June 2010

Detailed Description

All subjects are being studied using the same procedure. The study schedule takes place from 8 a.m. to 12 a.m. every time. Each subject shows up on one single day. Subjects are to show up fasting overnight with a break in insulin and/or oral antidiabetic treatment. The study eye of each subject will be selected by randomisation. We seek to have an equal distribution of right and left eyes overall. A first set of images will be taken after 5 minutes in "standardised daylight", in a room without light from outside, which eliminates any concerns about weather variations. After this the room is completely darkened. 2 set of images will be taken in the dark adapted state after 20 and 40 minutes. Subsequently the patient ingests the OGTT and will reach maximum blood glucose level after about 60-90 minutes. At this time, the subjects undergo the same "photo session" as above with high blood glucose levels.

Interventions

  • Dietary Supplement: Oral Glucose Tolerance Test (OGTT)
    • 75 g of glucose dissolved in 250 mL water.

Arms, Groups and Cohorts

  • Type 2 DM
    • This group includes subjects diagnosed with type 2 diabetes mellitus with none or minimal diabetic retinopathy.

Clinical Trial Outcome Measures

Primary Measures

  • Vessel caliber
    • Time Frame: 1 day

Secondary Measures

  • Blood glucose level
    • Time Frame: 1 day
    • Capillary samples.

Participating in This Clinical Trial

Inclusion Criteria

  • Type 2 diabetic individuals. – minimal or no diabetic retinopathy defined by no more than five microaneurysms or dot hemorrhages per eye on three non-stereoscopic 50 degree color fundus photographs Exclusion Criteria:

  • Test individuals with significant cataract, prior surgery to the eye, diabetic retinopathy, other serious eye disease, hypertension, other serious systemic disease

Gender Eligibility: All

Minimum Age: 17 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Glostrup University Hospital, Copenhagen
  • Provider of Information About this Clinical Study
    • Stig Holfort, MD, Glostrup University Hospital,Copenhagen
  • Overall Official(s)
    • Stig K Holfort, MD, Principal Investigator, Glostrup University Hospital, Copenhagen

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.